PharmApprove

PharmApprove PharmApprove is a leader in the field of strategic regulatory, drug and device development and scientific communications.

Our core offering is our FDA Advisory Committee Preparation Practice, which helps teams deliver powerful presentations and prepare to answer questions persuasively using time-tested methodologies we’ve created over the course of over 150 projects.

10/06/2020

Join Lisa Peluso and Kaia Agarwal for an engaging half-day tutorial on Preparing for an FDA Advisory Committee Meeting

Meeting and greeting at
06/02/2019

Meeting and greeting at

23/02/2018

We need your help in meeting our goal of 10,000 clicks by , next week on Wednesday, February 28! For every click, Lundbeck will donate $1 (up to $10,000) to a NORD research fund! Help us support rare disease research by simply clicking on the link here: http://bit.ly/2khfH5J

P.S. - you can click more than once! :D

13/02/2018

Did you know that Rare Disease Day is a global event? Check out this map to see where you can on and stay tuned for events happening on BioMarin campus! http://bit.ly/2BgjFpB

Retweeted FDA Medical Devices ():FDA Sets Inaugural Meeting of First-Ever Patient Engagement Advisory Committee https://...
25/07/2017

Retweeted FDA Medical Devices ():

FDA Sets Inaugural Meeting of First-Ever Patient Engagement Advisory Committee https://t.co/T18fcfXQvj https://t.co/BW2keDcDOQ

FDA Sets Inaugural Meeting of First-Ever Patient Engagement Advisory Committee Posted on July 25, 2017 by FDA Voice By: Kathryn O’Callaghan and Jeffrey Shuren, M.D., J.D. Imagine checking your blood sugar levels several times a day with a glucose meter to keep your diabetes under control. Or maybe y...

NICE u-turn backs use of Teva’s asthma biologic https://t.co/LJGRjOgC3P
25/07/2017

NICE u-turn backs use of Teva’s asthma biologic https://t.co/LJGRjOgC3P

The National Institute for Health and Care Excellence (NICE) is now backing routine NHS commissioning of Teva’s Cinqaero to treat a severe form of asthma after having initially been minded to block the drug’s use. - News - PharmaTimes

22/06/2017

Retweeted BIO Intl Convention ():

Less than 10% of public biotechs have a woman as CEO, and just over 1% have a woman as Chair of the Board. https://t.co/07huwzwVan

28/05/2017

For patients who’ve succeeded in knocking out a bad urinary tract infection (UTI) with antibiotic treatment, it’s frustrating to have that uncomfortable burning sensation flare back up. Resea…

FDA Advisory Committee Gives Thumbs Up for L-glutamine for Sickle Cell Disease https://t.co/J2eMt02Xkm via
25/05/2017

FDA Advisory Committee Gives Thumbs Up for L-glutamine for Sickle Cell Disease https://t.co/J2eMt02Xkm via

The FDA Advisory Committee voted 10-to-3 in favor of approving Endari (L-glutamine) for sickle cell disease.

Address

NJ

Alerts

Be the first to know and let us send you an email when PharmApprove posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PharmApprove:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram